FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/10/096574 [Registered on: 29/10/2025] Trial Registered Prospectively
Last Modified On: 25/02/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   Ayurvedic Management of Sciatica (Gridhrasi) through Koshtha Shodhana with Eranda Sneha and Vaitarana Basti  
Scientific Title of Study   An Open Label Single Arm Clinical Study To Evaluate The Efficacy Of Koshtha Shodhana With Eranda Sneha Followed By Vaitarana Basti In Yogabasti Pattern In The Management Of Gridhrasi (Sciatica) 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Pavanbhai Jerambhai Sorathiya 
Designation  PG Scholar 
Affiliation  G. J. Patel Institute Of Ayurvedic Studies And Research 
Address  Department Of Panchakarma, OPD No. 15, S. G. Patel Ayurveda Hospital And Maternity Home, New Vallabh Vidyanagar, Anand, Gujarat, India-388120

Anand
GUJARAT
388120
India 
Phone  6353085168  
Fax    
Email  pavansorathiya1604@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Suma K J 
Designation  Associate Professor 
Affiliation  G. J. Patel Institute Of Ayurvedic Studies And Research 
Address  Department Of Panchakarma, OPD No. 15, S. G. Patel Ayurveda Hospital And Maternity Home, New Vallabh Vidyanagar, Anand, Gujarat, India-388120

Anand
GUJARAT
388120
India 
Phone  9742786607  
Fax    
Email  sumakumble@outlook.com  
 
Details of Contact Person
Public Query
 
Name  Dr Suma K J 
Designation  Associate Professor  
Affiliation  G. J. Patel Institute Of Ayurvedic Studies And Research 
Address  Department Of Panchakarma, OPD No. 15, S. G. Patel Ayurveda Hospital And Maternity Home, New Vallabh Vidyanagar, Anand, Gujarat, India-388120

Anand
GUJARAT
388120
India 
Phone  9742786607  
Fax    
Email  sumakumble@outlook.com  
 
Source of Monetary or Material Support  
S. G. Patel Ayurveda Hospital And Maternity Home, New Vallabh Vidyanagar, Anand, Gujarat, India- 388120 
 
Primary Sponsor  
Name  Dr Pavanbhai Jerambhai Sorathiya 
Address  Department Of Panchakarma, OPD No. 15, S. G. Patel Ayurveda Hospital And Maternity Home, New Vallabh Vidyanagar, Anand, Gujarat, India-388120 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Pavanbhai Jerambhai Sorathiya  S. G. Patel Ayurveda Hospital And Maternity Home  Department Of Panchakarma, OPD No. 15, S. G. Patel Ayurveda Hospital And Maternity Home, New Vallabh Vidyanagar, Anand, Gujarat, India-388121
Anand
GUJARAT 
6353085168

pavansorathiya1604@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
G.J.Patel Institute Of Ayurvedic Studies And Research And S.G.Patel Ayurveda Hospital And Maternity Home Institutional (Human) Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:M543||Sciatica. Ayurveda Condition: GRUDHRASI,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
Intervention  Koshtha Shodhana with Eranda Sneha Followed by Vaitarana Basti in Yogabasti Pattern  Reference Vangasena Samhita - For Koshtha Shodhana Eranda Sneha will be administered in a dose ranging from 15-30 ml depending upon the Koshtha of the patient. Reference Vangasena Samhita Basti karma Adhikara In the proposed Yogabasti protocol, Vaitarana basti will be administered before food with a dosage of 306 ml. The Vaitarana Basti is prepared using specific proportions Guda (jaggery)24gm, Saindhava lavana (rock salt) 12gm, Murchita Tila taila 30ml, Chincha kalka (tamarind pulp) 48gm, Gopaya (cows milk) 192ml.  
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Participant fulfilling diagnostic criteria of Gridhrasi (Sciatica) like Ruk (Pain in lower back region radiating to lower limb) Stambha (Stiffness) Toda (Pricking like pain) Spandana (Twitching in all parts) and Associated symptoms like Aruchi (Anorexia) Tandra (Lethargy) and Gaurava (Heaviness in body)
Participants of either gender and age between 30 to 60 years
Participants willing to follow the prescribed Panchakarma protocol 
 
ExclusionCriteria 
Details  Participants not fit for Matra basti and/or Niruha Basti as per Ayurveda classics
Pregnant and Lactating women
Participants with major systemic illnesses known cases of Uncontrolled Diabetes Mellitus and Hypertension Cardiac disorders Morbid obesity and other diseases which interferes with the course of the treatment
Those who have undergone surgical treatment in affected joints
Participants who report any untoward symptoms during the period of the study 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Signs and Symptoms of Gridhrasi (Sciatica) and VAS (Visual Analogue Scale)
SLR Test, Sicard Sign, Bragard test, Dehasyapravakrata (Scoliosis), Range of movement of hip joint by Goniometer 
1st, 11th, 27th day 
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   01/12/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
The research proposal titled  An Open Label Single Arm Clinical Study to Evaluate the Efficacy of Koshtha Shodhana with Eranda Sneha Followed by Vaitarana Basti in Yogabasti Pattern in the Management of Gridhrasi (Sciatica). It aims to assess the therapeutic potential of classical Ayurvedic Panchakarma therapies in treating Gridhrasi, which correlates to sciatica in modern medicine. Sciatica, a prevalent and debilitating condition characterized by radiating pain from the lower back to the legs, affects up to 40% of the population and is linked to lifestyle factors such as prolonged sitting, poor posture, and mechanical strain. Modern treatments like NSAIDs and corticosteroids provide only temporary relief and often cause adverse effects, highlighting the need for holistic alternatives.
In Ayurveda, Gridhrasi is classified under Nanatmaja Vata Vyadhi, primarily caused by vitiation of Vata (and sometimes Kapha). The classical management involves Snehana, Swedana, and Basti Karma, among which Basti is the prime therapy for Vata Vyadhi. This clinical study proposes an integrated Panchakarma protocol involving three days of Koshtha Shodhana (purgation) with Eranda Sneha (castor oil) followed by eight days of Yogabasti a combination of Vaitarana Niruha Basti and Sahachara Taila Matra Basti.
A total of 30 patients aged 30–60 years will be selected from OPD/IPD based on diagnostic criteria for Gridhrasi. The study will assess improvements in pain, stiffness, pricking sensations, numbness, and functional mobility using both subjective and objective parameters such as VAS, SLR, Bragard, and Sicard tests. Statistical analysis will evaluate pre- and post-treatment outcomes.
The expected result is significant symptom relief and functional improvement through Shodhana and Shamana actions, offering a safe, cost-effective, and root-cause-oriented management approach for Gridhrasi. 
 
Close